Hala Yamout

Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy

G. Bakris, V. Perkovic, D. de Zeeuw, 2014, American Journal of Nephrology.

Management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration.

C. Ghossein, Scott T. Benken, H. Yamout, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease.

G. Bakris, I. Lazich, H. Yamout, 2014, Advances in chronic kidney disease.

Original Report: Patient-oriented, Translational Research Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy

G. Bakris, V. Perkovic, D. de Zeeuw, 2022 .

Impacts of center and clinical factors in antihypertensive medication use after kidney transplantation

B. Kasiske, M. Schnitzler, R. Ouseph, 2020, Clinical transplantation.

Physician Prevention of Acute Kidney Injury.

R. Rosa, M. Levin, H. Yamout, 2015, The American journal of medicine.

Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathy

G. Bakris, H. Yamout, Hala Yamout, 2016, Nature Reviews Nephrology.

27 – Use of Combination Therapies

G. Bakris, H. Yamout, Hala Yamout, 2018 .